Medullary thyroid carcinoma presenting with an initial CEA elevation

被引:14
作者
Abraham, Deepak [2 ]
Delbridge, Leigh [2 ]
Clifton-Bligh, Roderick [3 ]
Clifton-Bligh, Phillip [3 ]
Grodski, Simon [4 ]
Robinson, Bruce G. [3 ]
Messina, Marinella
Sidhu, Stan [1 ,2 ]
机构
[1] Royal N Shore Hosp, Dept Endocrine & Oncol Surg, Kolling Inst Med Res, Canc Genet Unit, St Leonards, NSW 2065, Australia
[2] Univ Sydney, Royal N Shore Hosp, Endocrine Surg Unit, St Leonards, NSW 2065, Australia
[3] Univ Sydney, Royal N Shore Hosp, Dept Endocrinol, St Leonards, NSW 2065, Australia
[4] Monash Univ, Alfred Hosp, Endocrine Surg Unit, Prahran, Vic 3181, Australia
关键词
Carcinoembryonic antigen; Medullary thyroid carcinoma; CARCINOEMBRYONIC ANTIGEN LEVELS; CALCITONIN;
D O I
10.1111/j.1445-2197.2010.05350.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Carcinoembryonic antigen (CEA) is a tumour marker commonly associated with gastrointestinal malignancy. Patients presenting with an elevated CEA will therefore often undergo extensive investigations in order to elucidate an underlying gastrointestinal malignancy that may not be clinically apparent. However the GI tract is not the only source of CEA elevation. Methods: We present a series of patients presenting with raised CEA levels that were initially investigated for a gastrointestinal cause, but after work up were detected to have medullary thyroid cancer. Results: Four patients with raised CEA were evaluated for a gastrointestinal cause for the elevation. We discuss the non gastrointestinal causes for an elevated CEA. Conclusion: The paper highlights that in patients presenting with an elevated CEA, in whom a gastrointestinal cause has been ruled out, a tumour of neuroendocrine origin needs to be considered as a cause for the elevated CEA.
引用
收藏
页码:831 / 833
页数:3
相关论文
共 20 条
[1]   Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma [J].
Barbet, J ;
Campion, L ;
Kraeber-Bodéré, F ;
Chatal, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6077-6084
[2]   Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma [J].
Bockhorn, M ;
Frilling, A ;
Rewerk, S ;
Liedke, M ;
Dirsch, O ;
Schmid, KW ;
Broelsch, CE .
THYROID, 2004, 14 (06) :468-470
[3]  
BUSNARDO B, 1984, CANCER-AM CANCER SOC, V53, P278, DOI 10.1002/1097-0142(19840115)53:2<278::AID-CNCR2820530216>3.0.CO
[4]  
2-Z
[5]   Progression of medullary thyroid carcinoma:: assessment with calcitonin and carcinoembryonic antigen doubling times [J].
Giraudet, Anne Laure ;
Al Ghulzan, Abir ;
Auperin, Anne ;
Leboulleux, Sophie ;
Chehboun, Ahmed ;
Troalen, Frederic ;
Dromain, Clarisse ;
Lumbroso, Jean ;
Baudin, Eric ;
Schlumberger, Martin .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (02) :239-246
[6]   DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (03) :439-+
[7]   SPECIFIC CARCINOEMBRYONIC ANTIGENS OF HUMAN DIGESTIVE SYSTEM [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 122 (03) :467-&
[8]  
GOLD P, 1978, CANCER, V42, P1399, DOI 10.1002/1097-0142(197809)42:3+<1399::AID-CNCR2820420803>3.0.CO
[9]  
2-P
[10]  
Kebebew E, 2000, CANCER-AM CANCER SOC, V88, P1139, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO